AshleyCooperalmost 2 years ago
Nightingale to accelerate personalized medicine by analyzing 40,000 blood samples
Nightingale Health, the Finnish innovator of an internationally recognized biomarker testing technology for chronic disease screening, will analyze 40,000 blood samples from Finland's largest biobank, THL Biobank, acting under the National Institute for Health and Welfare.
Source: https://www.eurekalert.org/pub_releases/2018-03/nh-nta031218.phpOther commentsSign in to post comments. You don't have an account? Sign up now!
